Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US10751305 | TARO PHARMS | Solid-forming topical formulations for pain control |
Jan, 2031
(7 years from now) | |
US10350180 | TARO PHARMS | Solid-forming local anesthetic formulations for pain control |
Jan, 2031
(7 years from now) | |
US10603293 | TARO PHARMS | Solid-forming local anesthetic formulations for pain control |
Jan, 2031
(7 years from now) |
Drugs and Companies using LIDOCAINE; TETRACAINE ingredient
Market Authorisation Date: 29 June, 2006
Treatment: NA
Dosage: CREAM;TOPICAL
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8715624 | TARO PHARMS | Stable liquid desoximethasone compositions with reduced oxidized impurity |
May, 2026
(2 years from now) | |
US8277780 | TARO PHARMS | Stable liquid desoximethasone compositions with reduced oxidized impurity |
Sep, 2028
(4 years from now) |
Drugs and Companies using DESOXIMETASONE ingredient
Market Authorisation Date: 11 April, 2013
Treatment: Treatment of plaque psoriasis in patients 18 years of age or older
Dosage: SPRAY;TOPICAL
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic